BioCentury | Sep 25, 2020
Finance

Human genetics leading the pull of investors into neuro

...money raised. Beyond those, two companies —Redpin Therapeutics Inc....
BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...hired Anthony Doyle as SVP and CFO. He was CFO of Worldwide Clinical Trials Inc. Redpin Therapeutics Inc....
BioCentury | Mar 27, 2020
Emerging Company Profile

Redpin debuts chemogenetic platform for neurology, raises $15.5M

...specific cell population,” Redpin co-founder, President and CEO Elma Hawkins told BioCentury. Founded in 2017, Redpin Therapeutics Inc....
...five-fold lower than that required for the drug to act as nicotine substitute. COMPANY PROFILE Redpin Therapeutics Inc....
BioCentury | Mar 11, 2020
Finance

Arkin ramping up investments with $140M fund

...is developing therapies for cytopenias and myelodysplastic syndromes; oncolytic virus company Oncorus Inc.; chemogenetics company Redpin Therapeutics Inc....
BioCentury | Oct 15, 2018
Company News

Management tracks: Rhythm, Redpin

...Intarcia Therapeutics Inc. (Boston, Mass.) as CMO and global head of regulatory affairs. Neurology company Redpin Therapeutics Inc....
Items per page:
1 - 5 of 5
BioCentury | Sep 25, 2020
Finance

Human genetics leading the pull of investors into neuro

...money raised. Beyond those, two companies —Redpin Therapeutics Inc....
BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...hired Anthony Doyle as SVP and CFO. He was CFO of Worldwide Clinical Trials Inc. Redpin Therapeutics Inc....
BioCentury | Mar 27, 2020
Emerging Company Profile

Redpin debuts chemogenetic platform for neurology, raises $15.5M

...specific cell population,” Redpin co-founder, President and CEO Elma Hawkins told BioCentury. Founded in 2017, Redpin Therapeutics Inc....
...five-fold lower than that required for the drug to act as nicotine substitute. COMPANY PROFILE Redpin Therapeutics Inc....
BioCentury | Mar 11, 2020
Finance

Arkin ramping up investments with $140M fund

...is developing therapies for cytopenias and myelodysplastic syndromes; oncolytic virus company Oncorus Inc.; chemogenetics company Redpin Therapeutics Inc....
BioCentury | Oct 15, 2018
Company News

Management tracks: Rhythm, Redpin

...Intarcia Therapeutics Inc. (Boston, Mass.) as CMO and global head of regulatory affairs. Neurology company Redpin Therapeutics Inc....
Items per page:
1 - 5 of 5